ZOLGENSMA Trademark
Trademark Overview
On Monday, January 18, 2021, a trademark application was filed for ZOLGENSMA with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA trademark a serial number of 79309720. The federal status of this trademark filing is REGISTERED as of Tuesday, October 12, 2021. This trademark is owned by NOVARTIS AG. The ZOLGENSMA trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
General Information
| Serial Number | 79309720 |
| Word Mark | ZOLGENSMA |
| Filing Date | Monday, January 18, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 12, 2021 |
| Registration Number | 6513679 |
| Registration Date | Tuesday, October 12, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 27, 2021 |
Trademark Statements
| Description of Mark | The mark consists of a small section of a DNA helix above and to the left of the letter "Z" in the word "ZOLGENSMA", which is in lowercase; "ZOLGEN" and the left side and middle bars of the helix are dark magenta and "SMA" and the right side of the helix are green. |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
| Indication of Colors claimed | The color(s) dark magenta and green is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 5, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Monday, April 18, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, March 29, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, March 29, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, January 12, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 12, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 27, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 27, 2021 | PUBLISHED FOR OPPOSITION |
| Sunday, July 11, 2021 | REFUSAL PROCESSED BY IB |
| Wednesday, July 7, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 22, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 18, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 18, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 18, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 17, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, June 17, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 17, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, June 17, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 17, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, June 17, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, May 27, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, May 27, 2021 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 26, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, May 25, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 18, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, May 11, 2021 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, May 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, May 4, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, April 29, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Featured Names
No names found.
